<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00746044</url>
  </required_header>
  <id_info>
    <org_study_id>PHAO07-CLG/COVOL</org_study_id>
    <nct_id>NCT00746044</nct_id>
  </id_info>
  <brief_title>Measurement of MRP2 Function Using Urinary Coproporphyrins</brief_title>
  <acronym>COVOL</acronym>
  <official_title>Evaluation of the Ratio of Urinary Coproporphyrins I and III as a Potential Biomarker of MRP2 Function in Man</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Tours</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Tours</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Human Multidrug Related Protein 2 (MRP2) excretes several drugs and could therefore modulate
      their elimination. Individual's MRP2 activity is under genetic control. Thus it would be very
      useful to get an easily measurable biomarker reflecting individual's MRP2 activity. We aimed
      to investigate the ratio of urinary coproporphyrins I and III (UCP(I/I+III), known to be
      increased in patients with mutations in MRP2/ABCC2 gene.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2008</start_date>
  <completion_date type="Actual">April 2009</completion_date>
  <primary_completion_date type="Actual">April 2008</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Urinary coproporphyrins (I/I+III)ratio</measure>
    <time_frame>End of three 24-hours periods</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>ABCC2 polymorphisms</measure>
    <time_frame>At the time of entering in the study</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">40</enrollment>
  <condition>Healthy Subjects</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>Healthy volunteers &gt;18y, 20 male, 20 female</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      24h urine DNA
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        40 healthy subjects &gt; 18 y 20 male, 20 female
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy

          -  &gt; 18 y

          -  Affiliated to an health insurance

        Exclusion Criteria:

          -  Patient not able to understand or to comply to the protocol
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chantal LE GUELLEC</last_name>
    <role>Study Director</role>
    <affiliation>CHRU Tours</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHRU de TOURS</name>
      <address>
        <city>Tours</city>
        <zip>37000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 1, 2008</study_first_submitted>
  <study_first_submitted_qc>September 1, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 3, 2008</study_first_posted>
  <last_update_submitted>May 14, 2009</last_update_submitted>
  <last_update_submitted_qc>May 14, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 15, 2009</last_update_posted>
  <responsible_party>
    <name_title>University Hospital, Tours</name_title>
    <organization>University Hospital, Tours</organization>
  </responsible_party>
  <keyword>Healthy</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

